<DOC>
	<DOCNO>NCT00423007</DOCNO>
	<brief_summary>The primary objective study investigate efficacy safety bromfenac ophthalmic solution treatment subject history allergic conjunctivitis</brief_summary>
	<brief_title>Efficacy Safety Topical Bromfenac Ophthalmic Solution v . Placebo Subjects With Allergic Conjunctivitis</brief_title>
	<detailed_description />
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Conjunctivitis , Allergic</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Bromfenac</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>History clinically active allergic conjunctivitis Agree return require visit Agree avoid disallow med Known hypersensitivity bromfenac salicylate</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
</DOC>